Key insights
- Wells Fargo upgraded Oscar Health (OSCR) to Equal Weight, citing improving trends in the exchange market for 2026, particularly in Florida. The firm noted better-than-expected medical loss ratios and conservative risk adjustment bookings. Despite a revenue shortfall in Q1 2026, the company reported strong EPS and analyst earnings revisions are positive, with profitability expected this year. The upgrade suggests a more optimistic outlook for OSCR's near-term performance, potentially influencing sentiment in the health insurance sector.
Investing.com - Wells Fargo upgraded Oscar Health Inc (NYSE:OSCR) to Equal Weight from Underweight on Wednesday and raised its price target to $20 from $11. The stock has surged 43% year-to-date and trades near $20.50, though InvestingPro analysis suggests the company remains undervalued at current levels.
Analyst Stephen Baxter said the firm is increasingly comfortable with the trajectory of the exchange market in 2026, though visibility remains low beyond that period. The analyst noted payment integrity will remain a focus area.
Wells Fargo’s analysis of statutory filings indicates enrollment and morbidity outcomes on the exchanges are trending better than expected. The industry is showing material medical loss ratio improvement while appearing to book risk adjustment too conservatively, opposite of last year’s dynamic.
Florida, Oscar Health’s most important state representing approximately 64% of premiums, has seen membership decline 13.5% year-over-year. Medical loss ratios in the state improved 370 basis points year-over-year despite 640 basis points of potential conservatism on risk adjustment.
The upgrade reflects Wells Fargo’s assessment of improving conditions in the exchange market based on early 2026 data from regulatory filings. According to InvestingPro Tips, analysts predict Oscar Health will turn profitable this year with three analysts recently revising earnings upwards. For deeper insights, investors can access Oscar Health’s comprehensive Pro Research Report, available for this and 1,400+ other US equities.
In other recent news, Oscar Health Inc. reported impressive financial results for the first quarter of 2026. The company achieved earnings per share of $2.07, significantly surpassing analysts’ expectations of $1.06. However, Oscar Health faced a revenue shortfall during the same period. In addition to financial updates, the company announced changes to Mario Schlosser’s role within the organization. Schlosser, previously serving as President of Technology and Chief Technology Officer, has transitioned to the position of Co-Founder & Advisor to the CEO. He will continue to contribute to Oscar Health’s artificial intelligence and digital health projects and remain on the Board of Directors. These developments reflect the company’s ongoing strategic adjustments and financial performance.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
ProPicks AI evaluates OSCR alongside thousands of other companies every month using 100+ financial metrics. Using powerful AI to generate exciting stock ideas, it looks beyond popularity to assess fundamentals, momentum, and valuation. The AI has no bias—it simply identifies which stocks offer the best risk-reward based on current data with notable past winners that include Super Micro Computer (+185%) and AppLovin (+157%). Want to know if OSCR is currently featured in any ProPicks AI strategies, or if there are better opportunities in the same space?